NCT00347412 2022-07-25
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Cellectar Biosciences, Inc.
Phase 3 Completed
Clinical Trials
4 trialsNCT00499122 2018-01-02
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
University of Miami
Phase 2 Completed
NCT00345540 2015-03-10
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
Cellectar Biosciences, Inc.
Phase 2 Completed
NCT00960726 2012-07-30
NOV-002 in Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 2 Withdrawn